Market Overview:
The global artificial tissue heart valve market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in artificial heart valves, and rising demand for minimally invasive procedures. The transcatheter heart valve segment is expected to grow at a CAGR of 8.0% from 2018 to 2030, owing to the increasing demand for minimally invasive procedures.
Product Definition:
An artificial tissue heart valve is a prosthetic device that replaces a natural heart valve. It is made from synthetic materials, such as metals, plastics, or cloth and can be used to replace any of the four valves in the human heart.
Transcatheter Heart Valve:
Transcatheter heart valve is a kind of artificial heart valve which is used to treat the patients suffering from degenerative mitral and aortic valves. The transcatheter heart valve has an advantage over conventional surgical heart valves in that it requires no incision, and also provides better patient convenience. Transcatheter Heart Valve (THV) market size by region: North America (U.S.
Surgical Heart Valve:
The surgical heart valve is a medical device that is used to close the hole in the heart. It's main function is to stop blood from flowing out of the heart and into the lungs when there are problems with either of these organs. The artificial tissue heart valve does not require surgery, but it works along similar lines as a surgical one.
Application Insights:
Based on application, the market is segmented into aortic stenosis, aortic regurgitation and others. Aortic stenosis held the largest share in 2017 due to increasing prevalence of this condition. According to data published by the National Center for Biotechnology Information (NCBI) in 2015, around 12% of population aged above 60 years suffer from this condition which requires valve replacement surgery. Rising geriatric population and unhealthy lifestyle are factors contributing towards high demand for heart valves in developed countries such as U.S.
Regional Analysis:
North America dominated the global artificial tissue heart valve market in 2017. This is due to the increasing prevalence of valvular diseases, rising geriatric population, and high healthcare expenditure in this region. Moreover, improved medical facilities for treatment and diagnosis are also contributing towards the growth of this regional market.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatment options for heart disorders. Furthermore, an increase in government initiatives aimed at reducing hospital readmissions will boost demand for artificial tissue valves within Asia Pacific region over the forecast period.
Growth Factors:
- Increasing prevalence of heart valve diseases: The global prevalence of heart valve diseases is increasing due to the aging population and rising incidence of obesity and diabetes. This is expected to drive the demand for artificial tissue heart valves in the coming years.
- Technological advancements: The development of innovative technologies such as transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of heart valve diseases, resulting in increased adoption of artificial tissue heart valves.
- Growing awareness about benefits offered by artificial tissue heart valves: There is growing awareness among patients and healthcare professionals about the benefits offered by artificial tissue heart valves, which is likely to boost their demand in the coming years.
- Rising number of surgical procedures: The number of surgical procedures for replacing or repairing defective or damaged natural hearts valves is increasing globally, which will lead to an increase in demand for artificial tissue Heart Valves over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Artificial Tissue Heart Valve Market Research Report
By Type
Transcatheter Heart Valve, Surgical Heart Valve
By Application
Aortic Stenosis, Aortic Regurgitation, Others
By Companies
Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife, Suzhou Jiecheng Medical Technology Co., Ltd., Labcor Laboratórios Ltda, Braile Biomédica, MicroPort Scientific Corporation, Beijing Balance Medical Technology Co., Ltd., Myval
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Artificial Tissue Heart Valve Market Report Segments:
The global Artificial Tissue Heart Valve market is segmented on the basis of:
Types
Transcatheter Heart Valve, Surgical Heart Valve
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aortic Stenosis, Aortic Regurgitation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Edwards Lifesciences
- Medtronic
- Abbott
- Livanova
- Boston Scientific
- Cryolife
- Suzhou Jiecheng Medical Technology Co., Ltd.
- Labcor Laboratórios Ltda
- Braile Biomédica
- MicroPort Scientific Corporation
- Beijing Balance Medical Technology Co., Ltd.
- Myval
Highlights of The Artificial Tissue Heart Valve Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Transcatheter Heart Valve
- Surgical Heart Valve
- By Application:
- Aortic Stenosis
- Aortic Regurgitation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Artificial Tissue Heart Valve Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An artificial tissue heart valve is a medical device that helps to prevent heart failure. It is a small, thin tube that replaces part of the natural heart valve. The artificial tissue valve can help to keep your blood flowing smoothly and help reduce the risk of stroke.
Some of the major companies in the artificial tissue heart valve market are Edwards Lifesciences, Medtronic, Abbott, Livanova, Boston Scientific, Cryolife, Suzhou Jiecheng Medical Technology Co., Ltd., Labcor Laborat³rios Ltda, Braile Biom©dica, MicroPort Scientific Corporation, Beijing Balance Medical Technology Co., Ltd., Myval.
The artificial tissue heart valve market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Artificial Tissue Heart Valve Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Artificial Tissue Heart Valve Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Artificial Tissue Heart Valve Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Artificial Tissue Heart Valve Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Artificial Tissue Heart Valve Market Size & Forecast, 2018-2028
4.5.1 Artificial Tissue Heart Valve Market Size and Y-o-Y Growth
4.5.2 Artificial Tissue Heart Valve Market Absolute $ Opportunity
Chapter 5 Global Artificial Tissue Heart Valve Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Artificial Tissue Heart Valve Market Size Forecast by Type
5.2.1 Transcatheter Heart Valve
5.2.2 Surgical Heart Valve
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Artificial Tissue Heart Valve Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Artificial Tissue Heart Valve Market Size Forecast by Applications
6.2.1 Aortic Stenosis
6.2.2 Aortic Regurgitation
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Artificial Tissue Heart Valve Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Artificial Tissue Heart Valve Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Artificial Tissue Heart Valve Analysis and Forecast
9.1 Introduction
9.2 North America Artificial Tissue Heart Valve Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Artificial Tissue Heart Valve Market Size Forecast by Type
9.6.1 Transcatheter Heart Valve
9.6.2 Surgical Heart Valve
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Artificial Tissue Heart Valve Market Size Forecast by Applications
9.10.1 Aortic Stenosis
9.10.2 Aortic Regurgitation
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Artificial Tissue Heart Valve Analysis and Forecast
10.1 Introduction
10.2 Europe Artificial Tissue Heart Valve Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Artificial Tissue Heart Valve Market Size Forecast by Type
10.6.1 Transcatheter Heart Valve
10.6.2 Surgical Heart Valve
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Artificial Tissue Heart Valve Market Size Forecast by Applications
10.10.1 Aortic Stenosis
10.10.2 Aortic Regurgitation
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Artificial Tissue Heart Valve Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Artificial Tissue Heart Valve Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Artificial Tissue Heart Valve Market Size Forecast by Type
11.6.1 Transcatheter Heart Valve
11.6.2 Surgical Heart Valve
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Artificial Tissue Heart Valve Market Size Forecast by Applications
11.10.1 Aortic Stenosis
11.10.2 Aortic Regurgitation
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Artificial Tissue Heart Valve Analysis and Forecast
12.1 Introduction
12.2 Latin America Artificial Tissue Heart Valve Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Artificial Tissue Heart Valve Market Size Forecast by Type
12.6.1 Transcatheter Heart Valve
12.6.2 Surgical Heart Valve
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Artificial Tissue Heart Valve Market Size Forecast by Applications
12.10.1 Aortic Stenosis
12.10.2 Aortic Regurgitation
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Artificial Tissue Heart Valve Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Artificial Tissue Heart Valve Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Artificial Tissue Heart Valve Market Size Forecast by Type
13.6.1 Transcatheter Heart Valve
13.6.2 Surgical Heart Valve
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Artificial Tissue Heart Valve Market Size Forecast by Applications
13.10.1 Aortic Stenosis
13.10.2 Aortic Regurgitation
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Artificial Tissue Heart Valve Market: Competitive Dashboard
14.2 Global Artificial Tissue Heart Valve Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Edwards Lifesciences
14.3.2 Medtronic
14.3.3 Abbott
14.3.4 Livanova
14.3.5 Boston Scientific
14.3.6 Cryolife
14.3.7 Suzhou Jiecheng Medical Technology Co., Ltd.
14.3.8 Labcor Laboratórios Ltda
14.3.9 Braile Biomédica
14.3.10 MicroPort Scientific Corporation
14.3.11 Beijing Balance Medical Technology Co., Ltd.
14.3.12 Myval
